| abstract |
The present invention relates to a polypeptide comprising a human antibody Fc domain, an Fc-fusion protein comprising the same, and a use thereof, and more particularly, the present invention relates to a polypeptide which is a vaccine delivery platform applicable to all vaccine development studies, and based on the same. Molecular engineering designed Fc fusion protein can be used for vaccine development for a variety of diseases by increasing the efficiency of the intended vaccine as the affinity and binding capacity for low-affinity antibody receptors are enhanced. |